FdaApplication
ANDA 212626
Identifiers
- fda_app_no: ANDA212626
Properties
| Property | Value |
|---|---|
| applicant_name | SPECGX LLC |
| application_type | ANDA |
| approval_date | 2021-07-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VIGABATRIN | VIGABATRIN | 500MG/PACKET | FOR SOLUTION;ORAL |
1 product